ARTICLE | Emerging Company Profile
Clover: trimerizing fusion proteins
Chengdu-based Clover is targeting cancer and infectious disease pathways that depend on trimer formation
April 11, 2020 2:36 AM UTC
Clover is developing trimerized fusion proteins to target cancer and infectious disease pathways that depend on trimer formation.
The company has exclusive, worldwide rights to its Trimer-Tag platform from GenHunter Corp., which was co-founded by Sichuan Clover Biopharmaceuticals Inc. co-founder, President and Chairman Peng Liang...
BCIQ Company Profiles